An FDA notice says the agency is working closely with Cardinal Health to address the quality issues and pinpoint the cause of the issues. The FDA agrees with Cardinal’s recommendation about not using the affected products.
The Level 3 gowns affected provide moderate risk protection and are used in several surgical procedures, such as open-heart surgery and knee replacements.
At this time, the FDA is not aware of any patient harm due to the quality issue.
Cardinal Health reached out to customers directly Jan. 11 and Jan. 15.
More articles on clinical leadership and infection control:
Quarantined patient at Kentucky hospital was misdiagnosed, officials say
Physicians association sues US congressman, cites ‘reputational injury,’ after website visits drop
Japan reports first pneumonia case linked to China outbreak
